Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000880835 | SCV001023957 | benign | Mucopolysaccharidosis, MPS-III-C; Retinitis pigmentosa 73 | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001805927 | SCV002051030 | likely benign | not specified | 2021-12-10 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001275629 | SCV001460915 | likely benign | Mucopolysaccharidosis, MPS-III-C | 2020-06-07 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003948307 | SCV004764180 | likely benign | HGSNAT-related disorder | 2019-11-07 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |